Skip to main content

Table 2 The changes in VAS between two studied groups along the periods of the study

From: Photobiomodulation versus corticosteroid in the management of erosive oral lichen planus: a randomized controlled clinical trial

VAS

Photobiomodulation group (n = 22)

Control group (n = 22)

Ua

p*

Baseline

 Min. – Max

5.0 – 9.0

6.0 – 9.0

227.00

0.712

 Mean ± SD

7.14 ± 1.17

7.05 ± 0.84

 Median (IQR)

7.0(6.0 – 8.0)

7.0(6.0 – 8.0)

After 6 Weeks

 Min. – Max

3.0 – 5.0

3.0 – 7.0

211.00

0.443

 Mean ± SD

4.27 ± 0.77

4.64 ± 1.18

 Median (IQR)

4.0(4.0 – 5.0)

4.0(4.0 – 5.0)

After 12 Weeks

 Min. – Max

0.0 – 3.0

1.0 – 3.0

178.50

0.105

 Mean ± SD

1.32 ± 0.84

1.68 ± 0.65

 Median (IQR)

1.0(1.0 – 2.0)

2.0(1.0 – 2.0)

Decrease

5.82 ± 1.68

5.36 ± 0.95

212.0

0.468

  1. Statistically significant at p ≤ 0.05
  2. *p p value for comparing between the studied groups
  3. aU Mann Whitney test